Ayurveda and Yoga trial for preventing COVID 19 among quarantined individuals exposed to COVID 19 patients

Evaluation of the Prophylactic effect of Comprehensive Ayurveda and Mindfulness-based Yoga regimen among Quarantined individuals exposed to COVID 19 patients: A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/026147

Enrollment

604

Registered

2020-06-25

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: comprehensive Ayurveda and yoga regimen: The participants in the intervention group will receive comprehensive Ayurveda and yoga regimen/therapy which will be administered for the first

Eligibility

Inclusion criteria

Inclusion criteria: a) Quarantine individuals with a history of close contact or exposure to COVID 19 patients in the same household. b) Males and females of 18 years and older, in ambulatory condition (not bedridden) c) Not previously diagnosed with COVID-19 d) Absence of symptoms of COVID 19 such as fever, cough, sore throat, breathlessness, Acute respiratory infection etc. e) Willingness and ability to comply with trial and follow-up procedures. f) Ability to understand the nature of the trial and give written informed consent.

Exclusion criteria

Exclusion criteria: a) Suspected or confirmed current COVID-19 case as diagnosed by treating physician b) Psychological, familial, sociological, or geographical conditions that do not permit compliance with the protocol. c) Pregnant at the time of screening or lactating women d) History of taking immunosuppressant drugs e) Any other condition which the investigators feels, may interfere with the study outcomes

Design outcomes

Primary

Measure	Time frame
Incidence of confirmed COVID-19 positive cases detection in experimental arm compared to control Outcome would be reported as the percent of participants in each arm who have a confirmed SARS-CoV-2 infection during study treatment. Timepoint: Baseline, end of 6th week	—

Secondary

Measure	Time frame
a. Psychological distress among HCWs by using General Anxiety Disorder (GAD) and Patient Heath Questionnaire 9 (PHQ-9) b. Quality of Life among HWCs using short form 36 Questionnaire c. Routine Biochemical investigations such as CBC, Absolute Blood Count, Absolute neutrophil count, Absolute Lymphocyte count, LFT, KFT Timepoint: baseline , end of 6th week	—

Countries

India

Contacts

Public ContactDr Gautam Sharma

All India Institute of Medical Sciences, New Delhi

cimraiimsdelhi@gmail.com01126549325

Outcome results